Belgium· BE-AMP-SAM125115-00

Tobrex 0.3 %

A tobramycin product containing tobramycin, registered in Belgium by Novartis Pharma. The same ATC class is registered in 10 of our 19 countries.

ATC S01AA12

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTobrex 0.3 %ATCS01AA12REGISTER NO.BE-AMP-SAM125115-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Tobramycin is registered in 10 of 19 countries.

Countries holding a registration under ATC S01AA12 (tobramycin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Tobramycin · ATC S01AA12

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tobramycin
Manufacturer
Novartis Pharma
Country
Belgium (BE)
ATC code
S01AA12
ATC class
Tobramycin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0022897
    EUR 8.13
  • be_apb
    0728105

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tobramycin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tobramycin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Bramitob, Tobi
  • Bulgaria · Tобрекс, Тобрамизил
  • Cyprus · Bramitob, Ikobel
  • Czechia · Bramitob, Tobramycin Vioser
  • Germany · Bramitob, Gernebcin
  • Denmark · Nebcina, Tobi
  • Estonia · Tobramycin Via Pharma, Tobrex
  • Spain · Bramitob, Tobrabact
  • Finland · Tobi
  • France · Nebcine, Tobi
  • United Kingdom (Northern Ireland) · Bramitob, Munuza
  • Greece · Bramitob, Eyetobrin
  • Croatia · Bramitob, Tobrex
  • Hungary · Bramitob, Brulamycin
  • Ireland · Bramitob, Tobi
  • Iceland · Tobi Podhaler, Vantobra
  • Italy · Bramicil, Bramitob
  • Liechtenstein · Tobi Podhaler, Vantobra
  • Lithuania · Bramitob, Tobramycin Via Pharma
  • Luxembourg · Obracin, Tobi
  • Latvia · Bramitob, Tobramycin Via Pharma
  • Malta · Tobi, Tobrex
  • Netherlands · Bramitob, Obracin
  • Norway · Bramitob, Nebcina
  • Poland · Bramitob, Tobramycin Via Pharma
  • Portugal · Bramitob, Tobi
  • Romania · Tobi, Tobramicină Sun
  • Sweden · Bramitob, Nebcina
  • Slovenia · Tobrex
  • Slovakia · Bramitob, Tobrex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e55fc69a-a44f-43a8-8179-47bdb04cf298
GET /v1/drugs/e55fc69a-a44f-43a8-8179-47bdb04cf298?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye ointment",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Tobrex 0.3 %",
  "name_fr": "Tobrex 0.3 %",
  "name_nl": "Tobrex 0.3 %",
  "amp_code": "SAM125115-00",
  "strengths": [
    "3.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Tobramycin"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Tobramycin",
  "authorisation_numbers": [
    "BE125115"
  ]
}

See everything about tobramycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.